NCT03651882View on ClinicalTrials.gov

Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections

PHASE4CompletedINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

August 7, 2018

Primary Completion Date

January 10, 2022

Study Completion Date

January 10, 2022

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Oxytocin

Oxytocin given in a combined regimen: after delivery 10 IE of oxytocin are applied intramyometrially and 10 IE of oxytocin are given over an infusion of 1000ml of 0.9% NaCL over 12 hours intravenously.

DRUG

Carbetocin

Carbetocin is given 0.1mg intravenously as a bolus after delivery.

Trial Locations (1)

8091

University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT03651882 - Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections | Biotech Hunter | Biotech Hunter